Search for other papers by Joanna Bogusławska in
Google Scholar
PubMed
Search for other papers by Marlena Godlewska in
Google Scholar
PubMed
Search for other papers by Ewa Gajda in
Google Scholar
PubMed
Search for other papers by Agnieszka Piekiełko-Witkowska in
Google Scholar
PubMed
Introduction Autoimmune thyroid disease (AITD) is defined as a dysregulation of the immune system leading to autoimmune attack on the thyroid gland. It is the most common autoimmune disease affecting humans ( 1 ). The two major clinical
Search for other papers by Emilio Fiore in
Google Scholar
PubMed
Search for other papers by Francesco Latrofa in
Google Scholar
PubMed
Search for other papers by Paolo Vitti in
Google Scholar
PubMed
thyroid disease (AITD) and non-AITD patients, while epitopic region B was recognized to the greatest extent by HT patients [ 28 , 31 , 32 ]. Table 1 Prevalence of TAb according to use of IS Fig. 1 Box-whisker plot of urinary
Search for other papers by Grigoris Effraimidis in
Google Scholar
PubMed
Search for other papers by Jan G.P. Tijssen in
Google Scholar
PubMed
Search for other papers by Wilmar M. Wiersinga in
Google Scholar
PubMed
Introduction Autoimmune thyroid disease (AITD) is a multifactorial condition and genetic factors as well as environmental factors are thought to play a role in its pathogenesis. Twin studies suggest that genetic factors account for about 70
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Search for other papers by Liliana Ribeiro Santos in
Google Scholar
PubMed
Health Investigation and Innovation Institute (i3S), University of Porto, Porto, Portugal
Search for other papers by Inês Vasconcelos Bessa in
Google Scholar
PubMed
Health Investigation and Innovation Institute (i3S), University of Porto, Porto, Portugal
Public Health Unit, ACES Baixo Mondego, Coimbra, Portugal
Search for other papers by Adriana Gaspar da Rocha in
Google Scholar
PubMed
Department of Endocrinology, Hospital University Centre of São João, Porto, Portugal
Search for other papers by Celestino Neves in
Google Scholar
PubMed
Search for other papers by Cláudia Freitas in
Google Scholar
PubMed
Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal
Health Investigation and Innovation Institute (i3S), University of Porto, Porto, Portugal
Department of Pathology, Faculty of Medicine of the University of Porto, Porto, Portugal
Search for other papers by Paula Soares in
Google Scholar
PubMed
Introduction Autoimmune thyroid disease (AITD) is one of the most prevalent groups of autoimmune diseases ( 1 ). Hashimoto’s thyroiditis (HT) and Graves' disease (GD) are the most significant AITDs ( 2 ), GD being around ten times less common
Search for other papers by Tanja Diana in
Google Scholar
PubMed
Search for other papers by Christian Wüster in
Google Scholar
PubMed
Search for other papers by Paul D. Olivo in
Google Scholar
PubMed
Search for other papers by Angelica Unterrainer in
Google Scholar
PubMed
Search for other papers by Jochem König in
Google Scholar
PubMed
Search for other papers by Michael Kanitz in
Google Scholar
PubMed
Search for other papers by Artur Bossowski in
Google Scholar
PubMed
Search for other papers by Brigitte Decallonne in
Google Scholar
PubMed
Search for other papers by George J. Kahaly in
Google Scholar
PubMed
manifestations of Graves’ disease (GD) and are specific biomarkers [ 6 - 10 ] of this autoimmune thyroid disease (AITD). On the other hand, TSHR blocking Ab (TBAb) can also be found in AITD patients and may contribute to the hypothyroidism or atypical Hashimoto
Search for other papers by George J. Kahaly in
Google Scholar
PubMed
Autoantibodies (Ab) to the TSH receptor (TSHR) are responsible for many of the clinical manifestations of Graves' disease (GD) and are specific biomarkers of this autoimmune thyroid disorder (AITD) [ 1 , 2 , 3 ]. These Ab can be measured
Search for other papers by Yasmine Abdellaoui in
Google Scholar
PubMed
Search for other papers by Dimitra Magkou in
Google Scholar
PubMed
Search for other papers by Sofia Bakopoulou in
Google Scholar
PubMed
Search for other papers by Ramona Zaharia in
Google Scholar
PubMed
EA 4340, Université Versailles Saint Quentin en Yvelines, UFR Simone Veil Santé, Montigny le Bretonneux, France
Search for other papers by Marie-Laure Raffin-Sanson in
Google Scholar
PubMed
EA 4340, Université Versailles Saint Quentin en Yvelines, UFR Simone Veil Santé, Montigny le Bretonneux, France
Search for other papers by Laure Cazabat in
Google Scholar
PubMed
]. Autoimmune thyroid diseases (AITD) are relatively common in the general population, frequently showing a familial aggregation. Autoimmune hypothyroidism has been described in families with RTHβ [ 5 ]. Graves’ disease (GD) has also been described as isolated
Search for other papers by Berglind Jonsdottir in
Google Scholar
PubMed
Search for other papers by Markus Lundgren in
Google Scholar
PubMed
Search for other papers by Sara Wallengren in
Google Scholar
PubMed
Search for other papers by Åke Lernmark in
Google Scholar
PubMed
Search for other papers by Ida Jönsson in
Google Scholar
PubMed
Search for other papers by Helena Elding Larsson in
Google Scholar
PubMed
(TGAb), and the TSH receptor [ 1 ]. Thyroid autoimmunity may cause cellular damage and result in autoimmune thyroid disease (AITD), with two opposing clinical phenotypes: autoimmune hypothyroidism and Graves’ hyperthyroidism. Autoimmune hypothyroidism
Search for other papers by Bing Han in
Google Scholar
PubMed
Search for other papers by Chi Chen in
Google Scholar
PubMed
Search for other papers by Yi Chen in
Google Scholar
PubMed
Search for other papers by Ningjian Wang in
Google Scholar
PubMed
Search for other papers by Jie Yu in
Google Scholar
PubMed
Search for other papers by Jing Cheng in
Google Scholar
PubMed
Search for other papers by Yingchao Chen in
Google Scholar
PubMed
Search for other papers by Chunfang Zhu in
Google Scholar
PubMed
Search for other papers by Yingli Lu in
Google Scholar
PubMed
Background Autoimmune thyroid disease (AITD), including autoimmune hypothyroidism (Hashimoto thyroiditis) and autoimmune hyperthyroidism (Graves’ disease), affects 2–5% of the general population. Its risk factors included genetic
Department of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Search for other papers by Manassawee Korwutthikulrangsri in
Google Scholar
PubMed
Search for other papers by Chrysoula Dosiou in
Google Scholar
PubMed
Committee on Molecular Metabolism and Nutrition, University of Chicago, Chicago, Illinois, USA
Search for other papers by Alexandra M. Dumitrescu in
Google Scholar
PubMed
Department of Pediatrics, University of Chicago, Chicago, Illinois, USA
Committee on Genetics, University of Chicago, Chicago, Illinois, USA
Search for other papers by Samuel Refetoff in
Google Scholar
PubMed
reverse triiodothyronine (TrT3), and TSH levels while serum total triiodothyronine (TT3) was normal. Positive thyroid peroxidase antibodies indicated the presence of autoimmune thyroid disease (AITD). An assay using polyethylene glycol precipitation to